
Mary M. Lyons
Examiner (ID: 1163, Phone: (571)272-2966 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1653, 1645 |
| Total Applications | 662 |
| Issued Applications | 371 |
| Pending Applications | 93 |
| Abandoned Applications | 224 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17065870
[patent_doc_number] => 20210268085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => CELL-TARGETING MOLECULES COMPRISING DE-IMMUNIZED, SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES
[patent_app_type] => utility
[patent_app_number] => 17/228579
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 147516
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17228579
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/228579 | Cell-targeting molecules comprising de-immunized, Shiga toxin a subunit effectors and CD8+ t-cell epitopes | Apr 11, 2021 | Issued |
Array
(
[id] => 17783597
[patent_doc_number] => 11406702
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-08-09
[patent_title] => Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated
[patent_app_type] => utility
[patent_app_number] => 17/228699
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28860
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17228699
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/228699 | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated | Apr 11, 2021 | Issued |
Array
(
[id] => 19112812
[patent_doc_number] => 20240124562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => MONOCLONAL ANTIBODIES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/768818
[patent_app_country] => US
[patent_app_date] => 2021-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24706
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17768818
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/768818 | MONOCLONAL ANTIBODIES AND USES THEREOF | Apr 7, 2021 | Pending |
Array
(
[id] => 17183883
[patent_doc_number] => 20210330768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => METHODS OF TREATING FUNGAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/224888
[patent_app_country] => US
[patent_app_date] => 2021-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17224888
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/224888 | Methods of treating fungal infections | Apr 6, 2021 | Issued |
Array
(
[id] => 18436048
[patent_doc_number] => 20230183342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => ANTIBODIES TO NKP46 AND CONSTRUCTS THEREOF FOR TREATMENT OF CANCERS AND INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/995651
[patent_app_country] => US
[patent_app_date] => 2021-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16848
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995651
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995651 | ANTIBODIES TO NKP46 AND CONSTRUCTS THEREOF FOR TREATMENT OF CANCERS AND INFECTIONS | Apr 4, 2021 | Pending |
Array
(
[id] => 18363285
[patent_doc_number] => 20230144876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => IMMUNE INDUCER CONTAINING POLYNUCLEOTIDE-PEPTIDE CONJUGATE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
[patent_app_type] => utility
[patent_app_number] => 17/907531
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907531
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/907531 | IMMUNE INDUCER CONTAINING POLYNUCLEOTIDE-PEPTIDE CONJUGATE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | Mar 25, 2021 | Pending |
Array
(
[id] => 18701557
[patent_doc_number] => 11788056
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Induction of protective immunity against antigens
[patent_app_type] => utility
[patent_app_number] => 17/213619
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 32
[patent_no_of_words] => 36085
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17213619
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/213619 | Induction of protective immunity against antigens | Mar 25, 2021 | Issued |
Array
(
[id] => 16948312
[patent_doc_number] => 20210207003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => PROCESS TO REDUCE ENDOTOXIN IN GELATIN
[patent_app_type] => utility
[patent_app_number] => 17/210965
[patent_app_country] => US
[patent_app_date] => 2021-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10323
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17210965
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/210965 | PROCESS TO REDUCE ENDOTOXIN IN GELATIN | Mar 23, 2021 | Abandoned |
Array
(
[id] => 18642422
[patent_doc_number] => 11766475
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Food safety vaccine to control
[patent_app_type] => utility
[patent_app_number] => 17/207948
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 15
[patent_no_of_words] => 50607
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17207948
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/207948 | Food safety vaccine to control | Mar 21, 2021 | Issued |
Array
(
[id] => 18298886
[patent_doc_number] => 20230108572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => Method For Treating Cholesterol-Related Diseases
[patent_app_type] => utility
[patent_app_number] => 17/906110
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8482
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906110
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/906110 | Method For Treating Cholesterol-Related Diseases | Mar 18, 2021 | Abandoned |
Array
(
[id] => 18340235
[patent_doc_number] => 20230132184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => METHODS AND SYSTEMS FOR PHYSICAL EXPANSION AND IMAGING OF BIOLOGICAL SAMPLES
[patent_app_type] => utility
[patent_app_number] => 17/905864
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14824
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -88
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905864
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905864 | METHODS AND SYSTEMS FOR PHYSICAL EXPANSION AND IMAGING OF BIOLOGICAL SAMPLES | Mar 11, 2021 | Pending |
Array
(
[id] => 17385978
[patent_doc_number] => 20220033830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => FUNCTIONALIZATION OF ENDOGENOUS BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/189113
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17189113
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/189113 | FUNCTIONALIZATION OF ENDOGENOUS BACTERIA | Feb 28, 2021 | Pending |
Array
(
[id] => 18391689
[patent_doc_number] => 20230159907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => PERFORMANCE-ENHANCED PROTEASE VARIANTS VII
[patent_app_type] => utility
[patent_app_number] => 17/908554
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908554
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/908554 | PERFORMANCE-ENHANCED PROTEASE VARIANTS VII | Feb 24, 2021 | Pending |
Array
(
[id] => 18685384
[patent_doc_number] => 11781107
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-10
[patent_title] => Microorganisms engineered for muconate production
[patent_app_type] => utility
[patent_app_number] => 17/184580
[patent_app_country] => US
[patent_app_date] => 2021-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 8681
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17184580
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/184580 | Microorganisms engineered for muconate production | Feb 23, 2021 | Issued |
Array
(
[id] => 17065880
[patent_doc_number] => 20210268095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/180959
[patent_app_country] => US
[patent_app_date] => 2021-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88355
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17180959
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/180959 | ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF | Feb 21, 2021 | Abandoned |
Array
(
[id] => 18266021
[patent_doc_number] => 20230087263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => ANTI-CD19/ANTI-CD3 BISPECIFIC ANTIBODY, T CELLS SECRETING THE SAME, METHOD OF PREPARATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/800032
[patent_app_country] => US
[patent_app_date] => 2021-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17800032
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/800032 | ANTI-CD19/ANTI-CD3 BISPECIFIC ANTIBODY, T CELLS SECRETING THE SAME, METHOD OF PREPARATION AND USE THEREOF | Feb 15, 2021 | Issued |
Array
(
[id] => 17649941
[patent_doc_number] => 11352655
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Method of identification of methicillin-resistant
[patent_app_type] => utility
[patent_app_number] => 17/170912
[patent_app_country] => US
[patent_app_date] => 2021-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 22
[patent_no_of_words] => 4914
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17170912
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/170912 | Method of identification of methicillin-resistant | Feb 8, 2021 | Issued |
Array
(
[id] => 17792532
[patent_doc_number] => 20220251623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => Method and apparatus for avoiding false positive coliform testing
[patent_app_type] => utility
[patent_app_number] => 17/300020
[patent_app_country] => US
[patent_app_date] => 2021-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17300020
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/300020 | Method and apparatus for avoiding false positive coliform testing | Feb 8, 2021 | Abandoned |
Array
(
[id] => 16822764
[patent_doc_number] => 20210138057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => Anti-Microbial Immunomodulation
[patent_app_type] => utility
[patent_app_number] => 17/154536
[patent_app_country] => US
[patent_app_date] => 2021-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35767
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17154536
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/154536 | Anti-microbial immunomodulation | Jan 20, 2021 | Issued |
Array
(
[id] => 18780187
[patent_doc_number] => 11821898
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-21
[patent_title] => Rapid test for Lyme bacteria
[patent_app_type] => utility
[patent_app_number] => 17/152146
[patent_app_country] => US
[patent_app_date] => 2021-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5537
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 286
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17152146
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/152146 | Rapid test for Lyme bacteria | Jan 18, 2021 | Issued |